CHEMED CORPORATION vs FRESENIUS MEDICAL CARE AG, two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CHE and FMS diverge most: on debt / equity, CHE reads 0.17 and FMS reads 0.00; on p/b, CHE reads 8.46 and FMS reads 0.97. The rest of the comparable metrics sit closer together. What CHE's price implies is a bet that sits within the historical range (whole-company basis). What FMS's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CHE | FMS |
|---|---|---|
| Price | $532.52 | $25.66 |
| Market cap | $7.0B | $15.0B |
| Sector | Medical Care | Medical Care |
| Stage | Mature | Mature |
| Implied growth (priced in) | +5.9% | — |
| P/E | 26.8 | 14.1 |
| P/B | 8.46 | 0.97 |
| P/S | 2.71 | 0.70 |
| EV/EBITDA | 17.2 | 3.7 |
| Revenue growth | +3.4% | +1.5% |
| Operating margin | 13.3% | 11.7% |
| Net margin | 10.6% | 6.1% |
| Return on equity | 33.1% | 8.3% |
| Return on assets | 17.4% | 3.8% |
| Return on invested capital | 26.7% | 10.1% |
| FCF yield | 4.4% | 19.4% |
| Dividend yield | 0.4% | 1.6% |
| Debt / equity | 0.17 | 0.00 |
| Current ratio | 0.91 | 1.26 |
| Altman Z (solvency) | 10.00 | 1.81 |
| Piotroski F (quality) | 6 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.